Bonus BioGroup Ltd. (TLV:BONS)
Israel
· Delayed Price · Currency is ILS · Price in ILA 19.50
-0.80 (-3.94%)
Jul 1, 2025, 5:24 PM IDT
Bonus BioGroup Balance Sheet
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 6.86 | 12.94 | 53.62 | 79.55 | 16.09 | Upgrade
|
Short-Term Investments | - | 13.04 | - | - | - | Upgrade
|
Cash & Short-Term Investments | 6.86 | 25.98 | 53.62 | 79.55 | 16.09 | Upgrade
|
Cash Growth | -73.59% | -51.56% | -32.59% | 394.53% | 15220.00% | Upgrade
|
Other Receivables | 0.09 | 0.25 | 0.51 | 1.16 | 0.41 | Upgrade
|
Receivables | 0.09 | 0.25 | 0.51 | 1.16 | 0.41 | Upgrade
|
Prepaid Expenses | 0.24 | 0.21 | 0.31 | 0.3 | 0.24 | Upgrade
|
Total Current Assets | 7.19 | 26.44 | 54.43 | 81 | 16.74 | Upgrade
|
Property, Plant & Equipment | 15.83 | 18.05 | 19.77 | 14.96 | 5.73 | Upgrade
|
Long-Term Investments | - | - | - | 7.9 | 28.88 | Upgrade
|
Other Intangible Assets | 0.01 | 0.02 | 0.04 | - | - | Upgrade
|
Other Long-Term Assets | 0.38 | 0.37 | 0.37 | 0.46 | 0.1 | Upgrade
|
Total Assets | 23.41 | 44.89 | 74.61 | 104.32 | 51.44 | Upgrade
|
Accounts Payable | 1.01 | 1.41 | 1.95 | 3.99 | 1.56 | Upgrade
|
Accrued Expenses | 2 | 2.21 | 2.98 | 2.43 | 2.86 | Upgrade
|
Current Portion of Leases | 1.66 | 1.48 | 1.35 | 1.23 | 0.78 | Upgrade
|
Other Current Liabilities | 3.25 | 0.81 | 1.34 | 1.12 | 11.19 | Upgrade
|
Total Current Liabilities | 7.92 | 5.91 | 7.62 | 8.77 | 16.37 | Upgrade
|
Long-Term Leases | 8.53 | 9.67 | 10.6 | 11.12 | 4.38 | Upgrade
|
Total Liabilities | 16.45 | 15.58 | 18.22 | 19.89 | 20.75 | Upgrade
|
Common Stock | 303.32 | 302.66 | 300.79 | 296.52 | 156.65 | Upgrade
|
Retained Earnings | -337.6 | -309.78 | -281.25 | -242.55 | -152.47 | Upgrade
|
Comprehensive Income & Other | 41.25 | 36.42 | 36.85 | 30.45 | 26.5 | Upgrade
|
Shareholders' Equity | 6.96 | 29.31 | 56.39 | 84.43 | 30.68 | Upgrade
|
Total Liabilities & Equity | 23.41 | 44.89 | 74.61 | 104.32 | 51.44 | Upgrade
|
Total Debt | 10.19 | 11.16 | 11.95 | 12.35 | 5.15 | Upgrade
|
Net Cash (Debt) | -3.33 | 14.82 | 41.67 | 67.2 | 10.93 | Upgrade
|
Net Cash Growth | - | -64.44% | -37.99% | 514.71% | - | Upgrade
|
Net Cash Per Share | -0.00 | 0.01 | 0.04 | 0.06 | 0.01 | Upgrade
|
Filing Date Shares Outstanding | 1,168 | 1,168 | 1,168 | 1,154 | 1,004 | Upgrade
|
Total Common Shares Outstanding | 1,168 | 1,168 | 1,168 | 1,154 | 998.98 | Upgrade
|
Working Capital | -0.73 | 20.53 | 46.81 | 72.23 | 0.36 | Upgrade
|
Book Value Per Share | 0.01 | 0.03 | 0.05 | 0.07 | 0.03 | Upgrade
|
Tangible Book Value | 6.95 | 29.28 | 56.35 | 84.43 | 30.68 | Upgrade
|
Tangible Book Value Per Share | 0.01 | 0.03 | 0.05 | 0.07 | 0.03 | Upgrade
|
Machinery | 4.35 | 4.25 | 4.05 | 0.8 | 1.38 | Upgrade
|
Leasehold Improvements | 8.45 | 8.44 | 8.25 | 4.25 | 0.22 | Upgrade
|
Updated Nov 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.